CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES (Parenthetical) - USD ($) $ in Thousands		Mar. 31, 2025		Dec. 31, 2024
Statement of Financial Position [Abstract]
Cost	[1]	$ 369,526	[2],[3],[4]	$ 372,310	[5],[6],[7]
Preferred stock, par value (in dollars per share)		$ 0.01		$ 0.01
Preferred stock, shares authorized (in shares)		50,000,000		50,000,000
Preferred stock, shares issued (in shares)		525		525
Preferred stock, shares outstanding (in shares)		525		525
Common stock par value (in dollars per share)		$ 0.01		$ 0.01
Common stock, shares authorized (in shares)		450,000,000		450,000,000

[1] All investments were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s board of directors (the “Board”).

[2] Gross unrealized gains, gross unrealized losses, and net unrealized losses for federal income tax purposes totaled $17.3 million, $39.9 million and $22.7 million, respectively, for the March 31, 2025 investment portfolio. The tax cost of investments is $369.9 million.

[3] Non-income producing investments.

[4] The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). Unless otherwise indicated, all of the Company’s portfolio company investments are subject to restrictions on sales. As of March 31, 2025, the Company’s portfolio company investments that were subject to restrictions on sales totaled $346.8 million at fair value and represented 136.1% of the Company’s net assets. In addition, unless otherwise indicated, as of March 31, 2025, all investments are pledged as collateral as part of the Company’s revolving credit facility.

[5] Gross unrealized gains, gross unrealized losses, and net unrealized losses for federal income tax purposes totaled $16.4 million, $29.3 million and $12.9 million, respectively, for the December 31, 2024 investment portfolio. The tax cost of investments is $372.8 million.

[6] Non-income producing investments.

[7] The Company generally acquires its investments in private transactions exempt from registration under the Securities Act. Unless otherwise indicated, all of the Company’s portfolio company investments are subject to restrictions on sales. As of December 31, 2024, the Company’s portfolio company investments that were subject to restrictions on sales totaled $359.9 million at fair value and represented 136.4% of the Company’s net assets. In addition, unless otherwise indicated, as of December 31, 2024, all investments are pledged as collateral as part of the Company’s revolving credit facility.